Neither cabergoline nor bromocriptine has been associated with an increased risk of miscarriage, congenital malformations, or pregnancy
Most women with microprolactinomas are advised to stop taking the cabergoline when they confirm a positive pregnancy test. Some women with
by M Ono 2024 Cited by 171The dose of cabergoline at the first pregnancy was 0.25–9 mg/wk overall and 2–9 mg/wk in the resistant patients. Of the 93 pregnancies achieved on cabergoline
Hyperprolactinemia is one of the causes of sterility. Cabergoline is indicated in cases resistant to bromocriptine, but, usually, its administration is interrupted at the beginning of the pregnancy. A case of prolonged treatment with cabergoline during pregnancy is reported, without teratogenic effe
amounts in women who are not pregnant, and in large amounts during pregnancy Cabergoline effectively treats hyperprolactinemia, micro
Buy Cabergoline Here. men on cabergoline. cabergoline effect time. cabergoline dosage. cabergoline assays. cabergoline side effects. cabergoline for bringing
During pregnancy, Cabergoline should be used only when clearly needed. Discuss the risks and benefits with your doctor. It is unknown if Cabergoline passes into breast milk. However, Cabergoline may affect breast milk production. Breast-feeding while using Cabergoline is not recommended. Consult your doctor before breast-feeding.
Cabergoline appears to reduce the risk of OHSS in high-risk women, especially for moderate OHSS. The use of cabergoline does not affect the pregnancy outcome (clinical pregnancy rate, miscarriage rate), nor is there an increased risk of adverse events. Further research should consider the risk of ad
Although cabergoline did not contribute to the increment of estrous response and pregnancy rate, improvement of reproductive parameters in both
Comments